Administration of antigen by intralymphatic route in the rat. II. Results in tumor active immunotherapy (delta). Preliminary report
- PMID: 189786
Item in Clipboard
Administration of antigen by intralymphatic route in the rat. II. Results in tumor active immunotherapy (delta). Preliminary report
Boll Ist Sieroter Milan.
.
Abstract
Tumor growth and survival time were followed in rats transplanted with Morris hepatoma 5123 and previously injected with a crude homogenate of the same tumor by the intradermic or intralymphatic route. Female rats treated by the intralymphatic route showed a longer survival time and impaired tumor growth. Male rats did not show any difference.
Similar articles
-
Growth of transplanted rat tumors following administration of cell-free tumor antigens.Cancer Res. 1978 May;38(5):1208-12. Cancer Res. 1978. PMID: 205357
-
Administration of antigen by intralymphatic route in the rat I. Humoral response to soluble antigens. (delta). Preliminary report.Boll Ist Sieroter Milan. 1976 Jul 31;55(3):249-51. Boll Ist Sieroter Milan. 1976. PMID: 1016576
-
Solubilization of tumour-specific antigen from plasma membrane of an aminoazo-dye-induced rat hepatoma.Clin Exp Immunol. 1972 May;11(1):51-6. Clin Exp Immunol. 1972. PMID: 4338951 Free PMC article.
-
Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications.Expert Rev Anticancer Ther. 2009 Oct;9(10):1499-510. doi: 10.1586/era.09.103. Expert Rev Anticancer Ther. 2009. PMID: 19828011 Review.
-
Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.Cell Mol Immunol. 2006 Jun;3(3):197-203. Cell Mol Immunol. 2006. PMID: 16893500 Review.